alexa
Reach Us +44-1625-70898
Editor - Jianfei Yang | GlaxoSmithKline Pharmaceuticals Ltd | 18850
ISSN: 2476-1958

Journal of Inflammatory Bowel Diseases & Disorders
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Jianfei Yang

Jianfei Yang
Jianfei Yang
Principal Scientist
GlaxoSmithKline Pharmaceuticals Ltd
Cambridge
USA
GlaxoSmithKline Pharmaceuticals Ltd

Biography

Dr. Jianfei Yang is a principal scientist, project leader and immunologist at Tempero, GlaxoSmithKline, in Cambridge, MA, USA. He received a PhD in Pathology from Niigata University in Japan. He then obtained postdoctoral training in Dr. Ken Murphy’s lab at HHMI and Washington University. In the past 18 year, he has been studying the role of CD4+ T helper cells in immunity and diseases. He has 14 years of experience in immuno-inflammatory disease research and pharmaceutical drug development. He has published numerous papers and patents. He has been recognized as an expert in Th17 research and drug development in pharmaceutical industry.

Research Interest

Jianfei Yang’s research interests include the role of immune cells such as Th17 and Treg cells in innate and protective immunity, autoimmune and inflammatory diseases, and cancers. He is interested in drug discovery of small molecule and novel therapeutic monoclonal antibodies for the treatment of various diseases. He is also interested in immunotherapy for tumor and inflammatory diseases.

Certificate

Certificate

Global Speakers in the subject

Global Experts in the subject

Publications

Small Molecule Inhibitors Targeting the Th17 Cell Transcription Factor RORγt for the Treatment of Autoimmune Diseases

Jianfei Yang, Jill Skepner, Mark Trocha and Shomir Ghosh
Editorial: J Clin Cell Immunol 2013, 4: e111
DOI: 10.4172/2155-9899.1000e111
Top